Aspirin for the prevention of cardiovascular disease: recommendation statement.

摘要

The U.S. Preventive Services Task Force (USPSTF) recommends the use of aspirin in men 45 to 79 years of age when the potential benefit of a reduction in myocardial infarctions (Mis) outweighs the potential harm of an increase in gastrointestinal (GI) hemorrhage. A recommendation. The USPSTF recommends the use of aspirin in women 55 to 79 years of age when the potential benefit of a reduction in ischemic strokes outweighs the potential harm of an increase in GI hemorrhage. A recommendation. The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of aspirin for cardiovascular disease (CVD) prevention in men and women 80 years and older.